Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVONEX in CIDP
NCT00099489Phase 2Completed
- Sponsor
- Biogen
- Start
- Feb 2004
- Primary completion
- Feb 2006
- Modality
- Cytokines & Interferons
- Countries
- 4
01
Overview
A Phase 2 trial of interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), sponsored by Biogen. Started Feb 2004; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
Beyond the preview
Go deeper on NCT00099489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00099489.